Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Greenbaum

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary InfectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Nature|May 11, 2022
Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Cell|January 12, 2024
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Adam J Schoenfeld, Darwin Ye, et al.
Immunity|November 22, 2024
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanismsSiyu Sun, Eunae You, Jungeui Hong, et al.
Nature|May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Discovery|February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule ReactivatorAnna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Nature Communications|December 10, 2020
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Medrxiv : the Preprint Server for Health Sciences|August 9, 2020
Temporal and Spatial Heterogeneity of Host Response to SARS-CoV-2 Pulmonary InfectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Nature|May 11, 2022
Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Cell|January 12, 2024
Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancerDanish Memon, Adam J Schoenfeld, Darwin Ye, et al.
Immunity|November 22, 2024
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanismsSiyu Sun, Eunae You, Jungeui Hong, et al.
Nature|May 31, 2022
Author Correction: Fundamental immune-oncogenicity trade-offs define driver mutation fitnessDavid Hoyos, Roberta Zappasodi, Isabell Schulze, et al.
Cancer Discovery|February 13, 2025
Restoration of the Tumor Suppressor Function of Y220C-Mutant p53 by Rezatapopt, a Small-Molecule ReactivatorAnna M Puzio-Kuter, Lizhong Xu, Mary Kate McBrayer, et al.
Nature Communications|December 10, 2020
Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infectionNiyati Desai, Azfar Neyaz, Annamaria Szabolcs, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Nature Cancer|February 5, 2022
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R Parikh, Annamaria Szabolcs, Jill N Allen, et al.
Iscience|August 1, 2025
T cell epitope mapping reveals immunodominance of evolutionarily conserved regions within SARS-CoV-2 proteomeCansu Cimen Bozkus, Matthew Brown, Leandra Velazquez, et al.
Pageof 9